Internal Medicine, Pulmonary Disease · Surprise, AZ
NPI
1548263825
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
14961 W Bell Rd, Suite 175
Surprise, AZ, 85374
Phone (623) 242-9830
Groups this clinician bills Medicare through
Medicare paid, 2024
$627K
8,669 services
Medicare patients, 2024
1,332
Average age 76
Drug cost, 2024
$4.9M
4,470 prescriptions
Company payments, 2025
$1,746
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jugroop S Brar was code 99233 (hospital e&m - subsequent), 1,297 times for 509 patients. In total Jugroop S Brar billed 8,669 services in 73 codes, and Medicare paid $627K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,297 | 509 | $85.82 | $111K |
| 99291 Critical Care E&M | Facility | 768 | 290 | $153.65 | $118K |
| 99232 Hospital E&M - Subsequent | Facility | 731 | 342 | $56.74 | $41K |
| 99214 Office E&M - Established | Office | 621 | 319 | $86.39 | $54K |
| 99308 SNF E&M | Facility | 519 | 70 | $54.38 | $28K |
| 99223 Hospital E&M - Initial | Facility | 333 | 310 | $125.11 | $42K |
| 99454 E&M - Miscellaneous | Office | 280 | 53 | $33.17 | $9,287 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 251 | 176 | $11.89 | $2,983 |
| 99457 E&M - Miscellaneous | Office | 215 | 52 | $34.12 | $7,336 |
| Q3014 Telehealth originating site facility fee | Office | 169 | 134 | $21.17 | $3,578 |
| 99215 Office E&M - Established | Office | 126 | 102 | $123.04 | $16K |
| 99205 Office E&M - New | Office | 117 | 117 | $148.41 | $17K |
| 99309 SNF E&M | Facility | 113 | 23 | $78.69 | $8,892 |
| 94060 Pulmonary Function Testing | Office | 98 | 96 | $26.16 | $2,564 |
| 94726 Pulmonary Function Testing | Office | 98 | 96 | $38.61 | $3,784 |
By year: 2022 $393K for 8,485 services; 2023 $504K for 9,529 services; 2024 $627K for 8,669 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88738 General Laboratory | 67 | 67 | $4.91 | $329 |
Medicare prescription drug claims, 2024
In 2024, the drug Jugroop S Brar prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 732 prescriptions and refills. In total Jugroop S Brar wrote 4,470 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 732 | 1,025 | 270 | $20K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 511 | 742 | 127 | $468K |
| Montelukast Sodium Generic | 418 | 840 | 105 | $3,696 |
| Prednisone Generic | 211 | 254 | 87 | $648 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 188 | 303 | 66 | $37K |
| Breo Ellipta Fluticasone/Vilanterol | 157 | 196 | 33 | $77K |
| Spiriva Respimat Tiotropium Bromide | 154 | 193 | 29 | $102K |
| Ofev Nintedanib Esylate | 125 | 125 | 18 | $1.6M |
| Wixela Inhub Fluticasone Propion/Salmeterol | 122 | 157 | 34 | $15K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 106 | 145 | 34 | $89K |
| Fluticasone Propionate Generic | 105 | 198 | 50 | $2,663 |
| Fluconazole Generic | 104 | 162 | 30 | $7,334 |
| Azithromycin Generic | 99 | 118 | 51 | $586 |
| Theophylline Er Theophylline Anhydrous | 77 | 125 | 23 | $4,561 |
| Roflumilast Generic | 71 | 99 | 20 | $4,988 |
Brand drugs: - claims; generic drugs: 2,332 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jugroop S Brar $1,746 ($1,746 in general payments such as food, travel and fees) from 22 companies. The largest payer was Insmed, Inc. with $290.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 24 | $290 |
| GlaxoSmithKline, LLC. GSK | 27 | $281 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $262 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $200 |
| Viatris Specialty LLC | 5 | $124 |
| Electromed, Inc. ELMD | 7 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $63.68 |
| Baxter Healthcare BAX | 3 | $54.29 |
| Amgen Inc. AMGN | 3 | $50.67 |
| United Therapeutics Corporation UTHR | 2 | $39.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.